The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma BC Parker, MJ Annala, DE Cogdell, KJ Granberg, Y Sun, P Ji, X Li, ... The Journal of clinical investigation 123 (2), 2013 | 256 | 2013 |
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas FM Lang, A Hossain, J Gumin, EN Momin, Y Shimizu, D Ledbetter, ... Neuro-oncology 20 (3), 380-390, 2018 | 207 | 2018 |
Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions F Guo, BC Parker Kerrigan, D Yang, L Hu, I Shmulevich, AK Sood, F Xue, ... Journal of hematology & oncology 7, 1-11, 2014 | 163 | 2014 |
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target N Abdelfattah, P Kumar, C Wang, JS Leu, WF Flynn, R Gao, DS Baskin, ... Nature communications 13 (1), 767, 2022 | 155 | 2022 |
MiR‐506 suppresses proliferation and induces senescence by directly targeting the CDK4/6–FOXM1 axis in ovarian cancer G Liu, Y Sun, P Ji, X Li, D Cogdell, D Yang, BC Parker Kerrigan, ... The Journal of pathology 233 (3), 308-318, 2014 | 143 | 2014 |
Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment BC Parker, W Zhang Chinese journal of cancer 32 (11), 594, 2013 | 124 | 2013 |
Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours BC Parker, M Engels, M Annala, W Zhang The Journal of pathology 232 (1), 4-15, 2014 | 122 | 2014 |
Fusion genes and their discovery using high throughput sequencing MJ Annala, BC Parker, W Zhang, M Nykter Cancer letters 340 (2), 192-200, 2013 | 88 | 2013 |
Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas BCP Kerrigan, Y Shimizu, M Andreeff, FF Lang Cytotherapy 19 (4), 445-457, 2017 | 70 | 2017 |
Tumor vaccines for malignant gliomas VM Srinivasan, SD Ferguson, S Lee, SP Weathers, BCP Kerrigan, ... Neurotherapeutics 14 (2), 345-357, 2017 | 49 | 2017 |
Ionizing radiation augments glioma tropism of mesenchymal stem cells JG Thomas, BCP Kerrigan, A Hossain, J Gumin, N Shinojima, F Nwajei, ... Journal of neurosurgery 128 (1), 287-295, 2017 | 49 | 2017 |
Immune modulatory nanoparticle therapeutics for intracerebral glioma NK Yaghi, J Wei, Y Hashimoto, LY Kong, K Gabrusiewicz, EK Nduom, ... Neuro-oncology 19 (3), 372-382, 2017 | 44 | 2017 |
Retinal pigment epithelial cell death by the alternative complement cascade: role of membrane regulatory proteins, calcium, PKC, and oxidative stress P Yang, P Baciu, BCP Kerrigan, M Etheridge, E Sung, BA Toimil, ... Investigative ophthalmology & visual science 55 (5), 3012-3021, 2014 | 42 | 2014 |
Translational genomics in cancer research: converting profiles into personalized cancer medicine L Patel, B Parker, D Yang, W Zhang Cancer Biology & Medicine 10 (4), 214, 2013 | 20 | 2013 |
Linking inflammation and cancer: the unexpected SYK world J Fueyo, MM Alonso, BC Parker Kerrigan, C Gomez-Manzano Neuro-oncology 20 (5), 582-583, 2018 | 17 | 2018 |
Endovascular selective intra-arterial infusion of mesenchymal stem cells loaded with delta-24 in a canine model VM Srinivasan, J Gumin, KM Camstra, DE Collins, MM Chen, EJ Shpall, ... Neurosurgery 88 (1), E102-E113, 2021 | 15 | 2021 |
RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine BC Parker Kerrigan, D Ledbetter, M Kronowitz, L Phillips, J Gumin, ... Neuro-Oncology Advances 2 (1), vdaa132, 2020 | 14 | 2020 |
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma Y Shimizu, J Gumin, F Gao, A Hossain, EJ Shpall, A Kondo, BCP Kerrigan, ... Journal of neurosurgery 136 (3), 757-767, 2021 | 13 | 2021 |
Targeting the tumor microenvironment in brain metastasis N Giridharan, ICG Oliva, BJ O’Brien, BCP Kerrigan, AB Heimberger, ... Neurosurgery Clinics 31 (4), 641-649, 2020 | 12 | 2020 |
Stem cell therapy of gliomas BCP Kerrigan, A Hossain, S Yamashita, FF Lang Intracranial Gliomas Part III-Innovative Treatment Modalities 32, 124-151, 2018 | 12 | 2018 |